Press Release|

Ulrich Faessler appointed CEO of SHL Medical

Pressrelease 201712 800x480

Ulrich Faessler has been appointed CEO of SHL Medical.

Since the founding of SHL Group (hereinafter referred to as “SHL”) in the late 1980s, SHL’s founder Roger Samuelsson has been the CEO and Group President. For SHL to advance and adapt to the demands of the growing organization, a new global CEO role for SHL’s Medical division will be created.

The new global CEO for SHL Medical Holding will be Ulrich Faessler. Ulrich has been with SHL for over seven years and has been the Asian Managing Director for SHL Medical for the past five years. Ulrich will assume the global CEO role on January 1, 2018.

Roger Samuelsson, CEO of SHL Group, commented: “I am delighted that Ulrich has agreed to take on the responsibility of leading SHL Medical Holding. Ulrich knows SHL, our customers and the industry, and I’m convinced he’s the right person to lead the company in the future.”

Roger will remain as President of SHL Group and will work closely with Ulrich.

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News

ZUG, Switzerland, NOV 21, 2024 — SHL Medical, a world leader in self-injection solutions, today announced plans to establish SHL Advantec – a dynamic sub-group dedicated to providing tooling and automation solutions to the healthcare sector and other industries. The establishment of SHL Advantec is part of SHL Medical’s ambitious expansion strategy and ongoing commitment…